
A small choline pilot found biological changes in older APOE ε4 carriers. How the findings compare with NIH evidence on cognition and safety.

On November 12, 2026, UNC’s Nutrition Research Institute reported on a pilot study of choline supplementation in cognitively healthy APOE ε4 carriers. The study found higher choline and betaine levels in blood and cerebrospinal fluid after supplementation.
The peer-reviewed study was published in Alzheimer’s & Dementia: Translational Research & Clinical Interventions in 2026. According to UNC, it included 13 participants with an average age of 70. They received 2,200 milligrams of choline daily for six months.
UNC describes the work as an early test of whether a high dose was tolerated, reached the brain and produced measurable biological changes. That focus matters when reading the findings: the study examined how participants responded biologically to supplementation.
The report describes several observations:
The first point of interest is that the researchers could measure a response beyond blood alone. UNC’s account also draws attention to the accompanying changes in fats and disease-associated markers. Together, these observations give researchers a more specific set of biological findings to investigate.
For older adults, the immediate implication is a more focused conversation about choline. The amount used in the study describes a research intervention. UNC’s report does not recommend that readers adopt it as a daily supplement routine.
UNC compares the study amount with adult recommended intakes of 550 milligrams per day for men and 425 milligrams per day for women. Those figures put the intervention in context: the research involved substantially more choline than those reference amounts.
The NIH Office of Dietary Supplements identifies choline as a nutrient the body needs. Meeting that nutritional need and taking extra choline for memory are different questions. A nutrient’s established role in nutrition does not establish an added cognitive benefit from supplements.
For someone weighing a supplement, a discussion with a healthcare professional is more appropriate than self-prescribing a high dose. That conversation can separate several issues:
These are questions for reviewing evidence and personal circumstances, not a protocol derived from this pilot. Related reading on choline intake and dementia risk research can help keep dietary research separate from claims about a specific supplement regimen.
UNC describes some marker changes as potentially favorable. But the 13-person pilot over six months was too small to establish whether those changes were beneficial. It did not show that choline prevents Alzheimer’s disease or improves memory, independence or everyday functioning.
The participants were cognitively healthy APOE ε4 carriers. That defined group should not be treated as evidence about all older adults or about treating established dementia. Readers interested in the broader question can find related coverage of nutrition research focused on APOE ε4.
The NIH Office of Dietary Supplements summarizes a 2015 systematic review of 13 studies that found no clear cognitive improvement from choline supplements in healthy adults. Its fact sheet also describes a Cochrane review of 12 lecithin trials that found no clear clinical benefit for Alzheimer’s or Parkinsonian dementia.
These findings do not make the pilot’s biological observations irrelevant. They show why a report about changing markers needs to be read alongside research that assessed cognitive or clinical outcomes. A new biological finding and an established patient benefit are different levels of evidence.
The NIH also says further research is needed to clarify whether choline supplements benefit people with Alzheimer’s disease or other dementias. The current evidence therefore calls for a distinction between an interesting research lead and a useful treatment.
UNC reports that the supplement was well tolerated in this small study. That observation does not establish that the same amount is safe or appropriate for everyone.
The NIH Office of Dietary Supplements lists an adult tolerable upper intake level of 3,500 milligrams per day. It associates high choline intakes with fishy body odor, vomiting and sweating. Other reported concerns include low blood pressure and liver toxicity.
An upper intake level is not a personal intake target. Nor does being below that level guarantee safety for every older adult. The safety question remains separate from whether a supplement has any demonstrated cognitive benefit.
UNC identifies a larger randomized, placebo-controlled trial as the next research step. The purpose would be to test whether the biological changes translate into meaningful health benefits. Its report does not announce that such a follow-up trial has begun.
That next step should be judged by more than whether the same substances rise again. The central issue is whether the biological response connects with an outcome that matters to people. Memory, independence and everyday functioning are more meaningful to readers than a laboratory change on its own.
There is value in an early study that narrows the questions researchers need to ask. Here, the pilot gives a more concrete starting point for testing choline in cognitively healthy APOE ε4 carriers. That gives the next study a clear task: test whether the observed response has practical value.
For the long-term direction of cognitive health research, the distinction is worth preserving. Nutritional biology can point toward new questions. Progress comes when controlled studies connect those questions with benefits that people can experience in their lives.
Decisions about choline supplements sit with older adults and their healthcare professionals, while FitBrainLab supplies context for reading the research. FitBrainLab translates evidence on nutrition and cognitive aging for adults 60+. The publication’s focus is clear, practical guidance that respects readers’ independence without turning early findings into medical promises.
Follow FitBrainLab for research-led insights on memory, focus, brain aging, nutrition and mental fitness after 60. Stay connected for new articles, practical guidance and ideas for a sharper, more engaged life.



Build habits that support memory, focus and a curious, connected life.
Read the Blog